X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-9-2023-9584.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-for-week-of-june-28-2023-96236.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-14-2023-63954.pdf
https://www.prnewswire.com/news-releases/endo-launches-prevduo-neostigmine-methylsulfate-and-glycopyrrolate-injection-the-first-and-only-fda-approved-neostigmineglycopyrrolate-combination-pre-filled-syringe-301847772.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-8-2023-15780.pdf
https://www.indianpharmapost.com/news/lupin-receives-approval-from-usfda-for-glycopyrrolate-injection-usp-13705
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-4-2023-52000.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-28-2022-95999.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212871
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-pharma-gets-usfda-nod-for-generic-version-of-glycopyrrolate-injection/articleshow/95223039.cms
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214635
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216407
https://www.prnewswire.com/news-releases/piramal-critical-care-launches-first-to-market-generic-zinc-sulfate-injection-in-the-us-301608664.html
http://www.pharmafile.com/news/730650/nhs-scotland-recommends-chiesi-s-trimbow-asthma
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213698
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212467
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-8-2022-1654674832.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-6-2022-1649740823.pdf
https://www.prnewswire.com/news-releases/endo-launches-first-generic-version-of-cuvposa-glycopyrrolate-oral-solution-301454073.html
https://www.biospace.com/article/releases/edenbridge-pharmaceuticals-announces-u-s-fda-approval-of-dartisla-odt-glycopyrrolate-orally-disintegrating-tablets/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214213
https://www.zyduscadila.com/public/pdf/pressrelease/Zydus-Cadila-receives-final-approval-from-USFDA-for-Glycopyrrolate-Injection.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212591
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-22-2021-1632297403.pdf
https://www.catalent.com/catalent-news/catalent-to-supply-edenbridge-pharmaceuticals-with-a-fast-dissolve-zydis-formulation-of-glycopyrrolate-intended-as-adjunctive-therapy-for-patients-with-peptic-ulcer/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212802
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-17-2021-1613546616.pdf
http://www.pharmafile.com/news/566249/european-approval-astrazenecas-trixeo-aerospace-moderate-severe-copd
https://www.raps.org/news-and-articles/news-articles/2020/7/fda-approvals-roundup-tecartus-breztri-aerosphere
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213238
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213238
https://www.novartis.com/news/media-releases/novartis-phase-iii-iridium-data-lancet-respiratory-medicine-show-benefit-enerzair-breezhaler-qvm149-first-class-inhaled-labalamaics-combination-uncontrolled
https://www.astrazeneca.com/media-centre/press-releases/2020/bevespi-aerosphere-approved-in-china-for-patients-with-copd.html
http://www.pmlive.com/pharma_news/novartis_asthma_triple_heads_chmps_latest_meeting_1339751
https://www.prnewswire.com/news-releases/sosei-heptares-notes-that-enerzair-breezhaler-qvm149-has-been-recommended-for-approval-in-the-european-union-for-treating-uncontrolled-asthma-301050859.html
https://www.ema.europa.eu/en/news/first-triple-combination-therapy-asthma-optional-electronic-sensor
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-8-2020-1586323768.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-26-2020-1582696769.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210083
https://www.prnewswire.com/news-releases/lilly-announces-agreement-to-acquire-dermira-300984850.html
https://www.hikma.com/newsroom/article-i4595-civica-rx-and-hikma-announce-shipments-of-heparin-and-seven-other-essential-injectable-medicines/
https://www.prnewswire.com/news-releases/sosei-heptares-announces-that-the-copd-treatment-ultibro-breezhaler-has-been-included-in-the-national-reimbursement-drug-list-in-china-300966545.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210246
Market Place
Share 
